文献速递垂体与肾上腺疾病骨质疏松与钙磷/甲状旁腺性腺与生殖内分泌

MEN4,MEN1的模仿者:三例表型异质性且携带独特CDKN1B突变患者的病例系列

MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

报告3例无亲缘关系、各携带独特种系CDKN1B突变(其中2个为新突变)的MEN4病例,表型从孤立性原发性甲状旁腺功能亢进到全谱内分泌表现,并首次报告MEN4中的泌乳素瘤和非典型胸腺类癌。

要点

  • 种系CDKN1B致病性变异导致常染色体显性遗传的MEN4综合征。
  • 3例患者分别表现为多腺体原发性甲状旁腺功能亢进伴微泌乳素瘤和多灶性无功能十二指肠胰腺神经内分泌肿瘤、单发甲状旁腺腺瘤所致原发性甲状旁腺功能亢进、无功能垂体微腺瘤及非典型胸腺类癌所致异位库欣综合征。
  • 首次报告MEN4中的泌乳素瘤和非典型胸腺类癌。

核心结论

  • 种系CDKN1B致病性变异导致MEN4综合征,本系列3个致病性变异所致表型凸显该综合征的异质性,范围从孤立性原发性甲状旁腺功能亢进到全谱内分泌表现。
  • 本文报告了MEN4中首例泌乳素瘤和非典型胸腺类癌病例。

研究设计与样本

  • 3例病例研究,包括临床表现、种系与肿瘤基因分析及家族史。
  • 研究场所为澳大利亚新南威尔士州悉尼的2家三级大学医院和澳大利亚首都领地堪培拉1家三级大学医院。

主要发现

  • 家族A:先证者发生多腺体原发性甲状旁腺功能亢进、微泌乳素瘤和多灶性无功能十二指肠胰腺神经内分泌肿瘤。
  • 家族B:先证者因单发甲状旁腺腺瘤诊断为原发性甲状旁腺功能亢进。
  • 家族C:先证者诊断为无功能垂体微腺瘤及非典型胸腺类癌所致异位库欣综合征。
  • 每例患者种系测序均发现独特CDKN1B变异,其中2个为新变异(c.179G > A, p.Trp60*;c.475G > A, p.Asp159Asn),1个为既往已报告变异(c.374_375delCT, p.Ser125*)。

关键数值与推荐

  • 种系CDKN1B致病性变异导致MEN4,为常染色体显性遗传性肿瘤综合征,可与原发性甲状旁腺功能亢进、垂体腺瘤和十二指肠胰腺神经内分泌肿瘤不同程度相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Germline CDKN1B pathogenic variants result in multiple endocrine neoplasia type 4 (MEN4), an autosomal dominant hereditary tumor syndrome variably associated with primary hyperparathyroidism, pituitary adenoma, and duodenopancreatic neuroendocrine tumors. OBJECTIVE: To report the phenotype of 3 unrelated cases each with a unique germline CDKN1B variant (of which 2 are novel) and compare these cases with those described in the current literature. DESIGN/METHODS: Three case studies, including clinical presentation, germline, and tumor genetic analysis and family history. SETTING: Two tertiary University Hospitals in Sydney, New South Wales, and 1 tertiary University Hospital in Canberra, Australian Capital Territory, Australia. OUTCOME: Phenotype of the 3 cases and their kindred; molecular analysis and tumor p27kip1 immunohistochemistry. RESULTS: Family A: The proband developed multiglandular primary hyperparathyroidism, a microprolactinoma and a multifocal nonfunctioning duodenopancreatic neuroendocrine tumor. Family B: The proband was diagnosed with primary hyperparathyroidism from a single parathyroid adenoma. Family C: The proband was diagnosed with a nonfunctioning pituitary microadenoma and ectopic Cushing's syndrome from an atypical thymic carcinoid tumor. Germline sequencing in each patient identified a unique variant in CDKN1B, 2 of which are novel (c.179G > A, p.Trp60*; c.475G > A, p.Asp159Asn) and 1 previously reported (c.374_375delCT, p.Ser125*). CONCLUSIONS: Germline CDKN1B pathogenic variants cause the syndrome MEN4. The phenotype resulting from the 3 pathogenic variants described in this series highlights the heterogenous nature of this syndrome, ranging from isolated primary hyperparathyroidism to the full spectrum of endocrine manifestations. We report the first described cases of a prolactinoma and an atypical thymic carcinoid tumor in MEN4.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Seabrook A, Wijewardene A, De Sousa S, et al. MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations. J Clin Endocrinol Metab. 2022. PMID: 35323929. doi:10.1210/clinem/dgac162

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。